NATIXIS - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIXIS ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,298
+1.4%
649
-1.7%
0.00%
Q2 2023$13,114
+10.3%
660
-4.9%
0.00%
Q1 2023$11,888
-12.5%
6940.0%0.00%
Q4 2022$13,582
-99.7%
694
-99.7%
0.00%
-100.0%
Q4 2021$4,920,000225,3940.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders